24.78
前日終値:
$25.49
開ける:
$25.37
24時間の取引高:
2.84M
Relative Volume:
0.80
時価総額:
$4.58B
収益:
$637.78M
当期純損益:
$239.40M
株価収益率:
20.81
EPS:
1.1909
ネットキャッシュフロー:
$307.21M
1週間 パフォーマンス:
-8.12%
1か月 パフォーマンス:
-9.03%
6か月 パフォーマンス:
-64.09%
1年 パフォーマンス:
-59.01%
Doximity Inc Stock (DOCS) Company Profile
名前
Doximity Inc
セクター
電話
(650) 549-4330
住所
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, TEM, BTSG, HQY, MMED
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
DOCS
Doximity Inc
|
24.78 | 4.71B | 637.78M | 239.40M | 307.21M | 1.1909 |
|
VEEV
Veeva Systems Inc
|
189.69 | 32.15B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
50.90 | 9.35B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.34 | 8.11B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
78.50 | 6.84B | 1.15B | 96.70M | -161.99M | 1.09 |
|
MMED
Minimed Group Inc
|
18.33 | 5.05B | 0 | 0 | 0 | 0.00 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-09 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | アップグレード | JP Morgan | Underweight → Neutral |
| 2026-01-20 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | 開始されました | RBC Capital Mkts | Outperform |
| 2026-01-08 | アップグレード | Truist | Hold → Buy |
| 2025-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-11-21 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | 開始されました | BMO Capital Markets | Market Perform |
| 2025-10-27 | アップグレード | BofA Securities | Neutral → Buy |
| 2025-10-10 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2025-10-01 | ダウングレード | Goldman | Neutral → Sell |
| 2025-07-09 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-06-02 | アップグレード | BTIG Research | Neutral → Buy |
| 2025-02-07 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | 開始されました | Stephens | Equal-Weight |
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-11-15 | 開始されました | Goldman | Neutral |
| 2024-11-14 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | アップグレード | Barclays | Equal Weight → Overweight |
| 2024-08-09 | アップグレード | Needham | Hold → Buy |
| 2024-07-18 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | アップグレード | JP Morgan | Underweight → Neutral |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2024-01-03 | 開始されました | Barclays | Equal Weight |
| 2024-01-02 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-08-09 | ダウングレード | Guggenheim | Buy → Neutral |
| 2023-08-09 | ダウングレード | Needham | Buy → Hold |
| 2023-08-03 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | 開始されました | Wells Fargo | Overweight |
| 2022-10-24 | 開始されました | Evercore ISI | In-line |
| 2022-10-13 | 開始されました | BTIG Research | Neutral |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-08-05 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-07-28 | 開始されました | Berenberg | Buy |
| 2022-05-18 | 繰り返されました | BofA Securities | Neutral |
| 2022-05-18 | 繰り返されました | Goldman | Buy |
| 2022-05-18 | 繰り返されました | Guggenheim | Buy |
| 2022-05-18 | 繰り返されました | Jefferies | Buy |
| 2022-05-18 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 繰り返されました | Needham | Buy |
| 2022-04-07 | 開始されました | Guggenheim | Buy |
| 2022-04-04 | 開始されました | BofA Securities | Neutral |
| 2022-02-11 | 開始されました | Goldman | Buy |
| 2021-12-14 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-12-02 | 開始されました | Jefferies | Buy |
| 2021-11-17 | 開始されました | Robert W. Baird | Outperform |
| 2021-11-10 | 繰り返されました | Canaccord Genuity | Buy |
| 2021-11-10 | 繰り返されました | Goldman | Neutral |
| 2021-11-10 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2021-11-10 | 繰り返されました | Needham | Buy |
| 2021-11-10 | 繰り返されました | Piper Sandler | Overweight |
| 2021-08-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-07-19 | 開始されました | Canaccord Genuity | Buy |
| 2021-07-19 | 開始されました | Goldman | Neutral |
| 2021-07-19 | 開始されました | JP Morgan | Overweight |
| 2021-07-19 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-07-19 | 開始されました | Piper Sandler | Overweight |
| 2021-07-19 | 開始されました | Raymond James | Outperform |
| 2021-07-19 | 開始されました | SVB Leerink | Outperform |
| 2021-07-19 | 開始されました | William Blair | Outperform |
すべてを表示
Doximity Inc (DOCS) 最新ニュース
Doximity (NASDAQ:DOCS) Receives "Outperform" Rating from Royal Bank Of Canada - MarketBeat
What Analysts Are Saying About Doximity Stock - Benzinga
Rhenman & Partners Asset Management AB Increases Stake in Doximity, Inc. - National Today
Rhenman & Partners Asset Management AB Increases Position in Doximity, Inc. $DOCS - MarketBeat
Blair William & Co. IL Acquires 345,390 Shares of Doximity, Inc. $DOCS - MarketBeat
What Wall Street predicts for Doximity Inc. stock price2026 Key Lessons & Verified Chart Pattern Signals - Naître et grandir
(DOCS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Victory Capital Management Inc. Acquires 921,533 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity (NASDAQ:DOCS) Director Sells $52,000.00 in Stock - MarketBeat
Assessing Doximity (DOCS) Valuation As Positive Analyst Sentiment Builds Around Its Telehealth Platform - simplywall.st
Is Doximity Inc in accumulation or distribution phaseJuly 2025 Patterns & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Breakouts Watch: Is Doximity Inc stock a hidden gemWall Street Watch & Safe Capital Allocation Plans - baoquankhu1.vn
Hims and Hers Expands Its Technology Driven Consumer Health Platform - The Globe and Mail
DOCS SEC FilingsDoximity Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Doximity Analysts Set $44.50 Average Price Target - National Today
Atlassian, C3.ai, Doximity, Braze, and Zeta Global Stocks Trade Up, What You Need To Know - Yahoo Finance
DOCS (NYSE: DOCS) insider to sell 2,000 shares via option exercise - Stock Titan
Is Doximity’s (DOCS) ViVE 2026 Pitch a Clue to Its Telehealth Moat? - Sahm
Is It Time To Reassess Doximity (DOCS) After A 62.5% One Year Slide? - Yahoo Finance
Bentley Systems, Guidewire Software, Health Catalyst, and Doximity Shares Skyrocket, What You Need To Know - The Globe and Mail
Intech Investment Management Trims Doximity Holdings - National Today
Ad Vital’s Dr. Shitel Patel Shares AI Prompting Strategies for Patient Growth in Doximity Article - FinancialContent
Doximity, Inc. (DOCS) Stock Analysis: Navigating a 62.87% Upside Potential in Health Information Services - DirectorsTalk Interviews
Intech Investment Management LLC Has $3.57 Million Holdings in Doximity, Inc. $DOCS - MarketBeat
William Blair Investment Management LLC Acquires 609,775 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. (NYSE:DOCS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Andra AP fonden Makes New Investment in Doximity, Inc. $DOCS - MarketBeat
Handelsbanken Fonder AB Acquires 180,700 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity CEO ViVE 2026 Talk Puts AI And Pharma Story In Focus - Sahm
Doximity, Inc. Hits New 52-Week Low at $23.57 Amid Market Decline - Markets Mojo
Doximity Investors' $31M Deal Over User Slowdown OK'd - Law360
ZoomInfo, SentinelOne, Toast, Doximity, and American Express Global Business Travel Shares Are Soaring, What You Need To Know - Yahoo Finance
Doximity’s $31 Million Investor Settlement Clears Initial Hurdle - Bloomberg Law News
Doximity Stock Hits Day Low of $23.58 Amid Price Pressure - Markets Mojo
Doximity, Inc. Stock Plummets to New 52-Week Low of $23.58 - Markets Mojo
Doximity Stock Analysts Adjust Ratings and Targets - National Today
Doximity, Inc. (NASDAQ:DOCS) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Doximity (DOCS) Price Target Decreased by 31.04% to 44.25 - Nasdaq
(DOCS) Risk Channels and Responsive Allocation - Stock Traders Daily
Doximity stock hits 52-week low at $23.65 amid challenging year - Investing.com Australia
Doximity (NASDAQ:DOCS) Sets New 12-Month Low on Analyst Downgrade - MarketBeat
Got $50,000? This Unbelievable SaaS Compounder Is Hiding in Plain Sight. - The Motley Fool
Piper Sandler raises Doximity stock price target on AI tools By Investing.com - Investing.com Australia
Doximity (NASDAQ:DOCS) Price Target Lowered to $33.00 at JPMorgan Chase & Co. - MarketBeat
Piper Sandler raises Doximity stock price target on AI tools - Investing.com
Piper Sandler Forecasts Strong Price Appreciation for Doximity (NASDAQ:DOCS) Stock - MarketBeat
Piper Sandler Raises Price Target for Doximity (DOCS) to $42 | D - GuruFocus
Doximity Stock: Why Analysts Are Signaling a Buy After a 67% Drop Last Year - TIKR.com
Doximity (DOCS) Soars 14% on Strong Earnings, Merger with AI-Powered Platform - MSN
Why Doximity Stock Plummeted Today - AOL.com
Canaccord Calls Doximity, Inc. (DOCS)’s Post-Earnings Selloff an Overreaction And Sees Long-Term Upside - Insider Monkey
Doximity Inc (DOCS) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):